Prochlorperazine for nausea and vomiting accompanied COVID‐19.

Prochlorperazine for nausea and vomiting accompanied COVID-19 Therefore, they proposed that combination of a 5-HT SB 3 sb receptor antagonist and a neurokinin receptor antagonist, which would inhibit the activation/sensitization of vagal afferents and nucleus of the solitary tract/area postrema, may be effective to relieve nausea and vomiting in patients with COVID-19. We read with interest the discussion by Andrews I et al i .1 on the mechanisms of nausea and vomiting accompanied coronavirus disease 2019 (COVID-19). [Extracted from the article]